B Cells, Antibodies, and More.
暂无分享,去创建一个
[1] D. Liggitt,et al. Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells , 2013, Nature Immunology.
[2] M. Shlomchik,et al. B Cell–Specific MHC Class II Deletion Reveals Multiple Nonredundant Roles for B Cell Antigen Presentation in Murine Lupus , 2015, The Journal of Immunology.
[3] D. Jayne,et al. B-cell depletion in the treatment of lupus nephritis , 2012, Nature Reviews Nephrology.
[4] J. Kearney,et al. Marginal Zone, but Not Follicular B Cells, Are Potent Activators of Naive CD4 T Cells1 , 2004, The Journal of Immunology.
[5] F. Nimmerjahn,et al. Intravenous immunoglobulin therapy: how does IgG modulate the immune system? , 2013, Nature Reviews Immunology.
[6] Amit Bar-Or,et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases , 2014, Nature.
[7] F. Delbos,et al. Multiple layers of B cell memory with different effector functions , 2009, Nature Immunology.
[8] P. Lipsky,et al. Disturbed Peripheral B Lymphocyte Homeostasis in Systemic Lupus Erythematosus1 , 2000, The Journal of Immunology.
[9] E. L. Prak,et al. Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus , 2008, Annals of the rheumatic diseases.
[10] G. Tsokos,et al. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. , 1996, The Journal of clinical investigation.
[11] R. Maciuca,et al. Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study. , 2013, Arthritis and rheumatism.
[12] Kenneth G. C. Smith,et al. B-cell-depleting induction therapy and acute cellular rejection. , 2009, The New England journal of medicine.
[13] F. Alt,et al. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair , 2004, Nature Reviews Immunology.
[14] K. Lai. Pathogenesis of IgA nephropathy , 2012, Nature Reviews Nephrology.
[15] C. Loddenkemper,et al. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. , 2010, Immunity.
[16] D. Isenberg,et al. Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus. , 2013, Arthritis and rheumatism.
[17] J. Cyster,et al. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. , 2005, Annual review of immunology.
[18] V. Hadjianastassiou,et al. Rituximab in renal transplantation , 2013, Transplant international : official journal of the European Society for Organ Transplantation.
[19] M. Krumbholz,et al. BAFF is elevated in serum of patients with Wegener's granulomatosis. , 2005, Journal of autoimmunity.
[20] J. Fechner,et al. BAFF Is Increased in Renal Transplant Patients Following Treatment with Alemtuzumab , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[21] D. Sansonno,et al. Activation‐induced cytidine deaminase in B cells of hepatits C virus‐related cryoglobulinaemic vasculitis , 2015, Clinical and experimental immunology.
[22] B. Ryffel,et al. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. , 1997, Journal of immunology.
[23] I. Sanz,et al. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. , 2007, Arthritis and rheumatism.
[24] R. Siegel,et al. Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.
[25] E. Thervet,et al. Combined Posttransplant Prophylactic IVIg/Anti-CD 20/Plasmapheresis in Kidney Recipients With Preformed Donor-Specific Antibodies: A Pilot Study , 2010, Transplantation.
[26] S. Nutt,et al. Germinal center B and follicular helper T cells: siblings, cousins or just good friends? , 2011, Nature Immunology.
[27] U. Panzer,et al. Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis. , 2008, Kidney international.
[28] P. van Paassen,et al. Regulatory B cells in ANCA-associated vasculitis , 2013, Annals of the rheumatic diseases.
[29] G. Remuzzi,et al. Rituximab in idiopathic membranous nephropathy. , 2012, Journal of the American Society of Nephrology : JASN.
[30] E. Ginzler,et al. Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE , 2013, Lupus.
[31] S. Swain,et al. Reciprocal regulation of polarized cytokine production by effector B and T cells , 2000, Nature Immunology.
[32] L. Turka,et al. B cells with immune-regulating function in transplantation , 2014, Nature Reviews Nephrology.
[33] M. Petri,et al. Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response , 2012, Annals of the rheumatic diseases.
[34] C. Croce,et al. The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells , 2015, Leukemia.
[35] H. Zola,et al. Blood group antibodies are made by CD5+ and by CD5− B cells , 1997, Immunology and cell biology.
[36] A. Loupy,et al. The impact of donor-specific anti-HLA antibodies on late kidney allograft failure , 2012, Nature Reviews Nephrology.
[37] R. Colvin,et al. Banff 2011 Meeting Report: New Concepts in Antibody‐Mediated Rejection , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[38] C. Cohen,et al. The contribution of B cells to renal interstitial inflammation. , 2007, The American journal of pathology.
[39] M. Rastaldi,et al. CD20-positive infiltrates in human membranous glomerulonephritis. , 2005, Journal of nephrology.
[40] D. Laplaud,et al. Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties. , 2015, Journal of the American Society of Nephrology : JASN.
[41] K. Fairfax,et al. The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity , 2013, Cytokine & Growth Factor Reviews.
[42] B. Diamond,et al. Selective dysregulation of the FcγIIB receptor on memory B cells in SLE , 2006, The Journal of Experimental Medicine.
[43] X. Jouven,et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. , 2013, The New England journal of medicine.
[44] Keiichiro Suzuki,et al. Roles of B‐1 and B‐2 cells in innate and acquired IgA‐mediated immunity , 2010, Immunological reviews.
[45] David Allman,et al. Regulation of peripheral B cell maturation. , 2006, Cellular immunology.
[46] K. Tarte,et al. Unique B Cell Differentiation Profile in Tolerant Kidney Transplant Patients , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[47] H. Rabb,et al. B cells limit repair after ischemic acute kidney injury. , 2010, Journal of the American Society of Nephrology : JASN.
[48] Irene Puga,et al. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes , 2013, Nature Reviews Immunology.
[49] T. Singh,et al. B cells mediate chronic allograft rejection independently of antibody production. , 2014, The Journal of clinical investigation.
[50] J. Michel,et al. Immune Responses Elicited in Tertiary Lymphoid Tissues Display Distinctive Features , 2010, PloS one.
[51] F. Carrat,et al. Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey. , 2012, Blood.
[52] A. Challa,et al. ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process , 2011, Annals of the rheumatic diseases.
[53] E. Ritz,et al. In situ production of TNF-α, IL-1β and IL-2R in ANCA-positive glomerulonephritis , 1993 .
[54] S. Gauld,et al. B-cell anergy: from transgenic models to naturally occurring anergic B cells? , 2007, Nature Reviews Immunology.
[55] A. Rajeswaran,et al. Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial , 2012, Arthritis Research & Therapy.
[56] N. Baumgarth. The double life of a B-1 cell: self-reactivity selects for protective effector functions , 2011, Nature Reviews Immunology.
[57] P. Milpied,et al. Switched-memory B cells remodel B cell receptors within secondary germinal centers , 2015, Nature Immunology.
[58] R. Colvin,et al. Chronic Humoral Rejection of Human Kidney Allografts Associates With Broad Autoantibody Responses , 2010, Transplantation.
[59] G. Cattoretti,et al. Commitment of B Lymphocytes to a Plasma Cell Fate Is Associated with Blimp-1 Expression In Vivo1 , 2000, The Journal of Immunology.
[60] M. Sayegh,et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. , 2011, The Journal of clinical investigation.
[61] S. Tangye,et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. , 2003, The Journal of clinical investigation.
[62] Hailong Meng,et al. CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype , 2014, Nature Immunology.
[63] C. Cunningham-Rundles,et al. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance , 2007, The Journal of experimental medicine.
[64] A. Gabrielli,et al. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. , 2012, Arthritis and rheumatism.
[65] A. Cappione,et al. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. , 2004, Arthritis and rheumatism.
[66] G. Silverman,et al. Protective Roles of Natural IgM Antibodies , 2012, Front. Immun..
[67] G. Tsokos,et al. T cells as a therapeutic target in SLE , 2015, Lupus.
[68] R. Colvin,et al. Chronic alloantibody mediated rejection. , 2012, Seminars in immunology.
[69] B. Volpe,et al. XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell development , 2009, The Journal of experimental medicine.
[70] G. Vidarsson,et al. A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. , 2014, Blood.
[71] D. Chaplin,et al. B Lymphocytes Induce the Formation of Follicular Dendritic Cell Clusters in a Lymphotoxin α–dependent Fashion , 1998, The Journal of experimental medicine.
[72] R. Pelanda,et al. This information is current as Signaling Transitional B Cells following Tonic BCR Differentiation of Immature B Cells into BAFF Receptor Signaling Aids the , 2010 .
[73] M. Shlomchik,et al. Germinal center selection and the development of memory B and plasma cells , 2012, Immunological reviews.
[74] K. P. Murphy,et al. Janeway's immunobiology , 2007 .
[75] D. Gladman,et al. Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials , 2012, Annals of the rheumatic diseases.
[76] M. Moser,et al. B Lymphocytes Regulate Dendritic Cell (Dc) Function in Vivo , 2000, The Journal of experimental medicine.
[77] R. Maciuca,et al. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. , 2012, Arthritis and rheumatism.
[78] David M. Beck,et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.
[79] M. Suthanthiran,et al. Identification of a B cell signature associated with renal transplant tolerance in humans. , 2010, The Journal of clinical investigation.
[80] S. Pillai,et al. The follicular versus marginal zone B lymphocyte cell fate decision , 2009, Nature Reviews Immunology.
[81] G. Springer,et al. Blood group isoantibody stimulation in man by feeding blood group-active bacteria. , 1969, The Journal of clinical investigation.
[82] M. Giger,et al. Cell Distance Mapping Identifies Functional T Follicular Helper Cells in Inflamed Human Renal Tissue , 2014, Science Translational Medicine.
[83] T. Randall,et al. B Cells Are Required for Generation of Protective Effector and Memory CD4 Cells in Response to Pneumocystis Lung Infection , 2006, The Journal of Immunology.
[84] D. Wishart,et al. Transplant Glomerulopathy, Late Antibody‐Mediated Rejection and the ABCD Tetrad in Kidney Allograft Biopsies for Cause , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[85] R. Redfield,et al. Murine Islet Allograft Tolerance Upon Blockade of the B-Lymphocyte Stimulator, BLyS/BAFF , 2012, Transplantation.
[86] R. V. van Lier,et al. B Cells Are Crucial for Both Development and Maintenance of the Splenic Marginal Zone1 , 2004, The Journal of Immunology.
[87] Kim L Kusser,et al. Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus. , 2009, Immunity.
[88] D. Rothstein,et al. Non-Antibody Mediated Roles of B Cells in Allograft Survival , 2014, Current Transplantation Reports.
[89] J. Thurman,et al. B Cell Subsets Contribute to Renal Injury and Renal Protection after Ischemia/Reperfusion , 2010, The Journal of Immunology.
[90] L. Sandu. CORTICOSTEROIDS IN LANDRY-GUILLAIN-BARRÉ-STROHL SYNDROME , 1974 .
[91] A. Salama,et al. Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis. , 2014, Rheumatology.
[92] M. Shlomchik,et al. Cutting Edge: B Cells Promote CD8+ T Cell Activation in MRL-Faslpr Mice Independently of MHC Class I Antigen Presentation1 , 2000, The Journal of Immunology.
[93] M. Shlomchik,et al. A Novel Mouse with B Cells but Lacking Serum Antibody Reveals an Antibody-independent Role for B Cells in Murine Lupus , 1999, The Journal of experimental medicine.
[94] A. Cherukuri,et al. Immunologic human renal allograft injury associates with an altered IL-10/TNF-α expression ratio in regulatory B cells. , 2014, Journal of the American Society of Nephrology : JASN.
[95] A. Naji,et al. B Cell-Mediated Antigen Presentation Is Required for the Pathogenesis of Acute Cardiac Allograft Rejection1 , 2006, The Journal of Immunology.
[96] G. Wallukat,et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. , 2005, The New England journal of medicine.
[97] R. Flavell,et al. Expansion or Elimination of B Cells In Vivo: Dual Roles for CD40- and Fas (CD95)-Ligands Modulated by the B Cell Antigen Receptor , 1996, Cell.
[98] J. Michel,et al. Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[99] M. Busslinger,et al. Pax5: the guardian of B cell identity and function , 2007, Nature Immunology.
[100] J. Lozano,et al. Comparative Transcriptional and Phenotypic Peripheral Blood Analysis of Kidney Recipients Under Cyclosporin A or Sirolimus Monotherapy , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[101] D. Isenberg,et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. , 2010, Immunity.
[102] T. Randall,et al. Effector and regulatory B cells: modulators of CD4+ T cell immunity , 2010, Nature Reviews Immunology.
[103] M. Ehrenstein,et al. The 'short' history of regulatory B cells. , 2008, Trends in immunology.
[104] W. Suki,et al. Bortezomib in kidney transplant desensitization: a case report. , 2009, Clinical transplants.
[105] A. El-Husseini,et al. Refractory Henoch-Schönlein purpura: atypical aetiology and management. , 2013, Journal of renal care.
[106] Graham M Lord,et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. , 2010, The Journal of clinical investigation.
[107] A. DeFranco,et al. B Cell–Specific Loss of Lyn Kinase Leads to Autoimmunity , 2014, The Journal of Immunology.
[108] V. Pascual,et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus , 2005, The Journal of experimental medicine.
[109] J. Ravetch,et al. Identification of a receptor required for the anti-inflammatory activity of IVIG , 2008, Proceedings of the National Academy of Sciences.
[110] Thomas Boehm,et al. Human Immunoglobulin M Memory B Cells Controlling Streptococcus pneumoniae Infections Are Generated in the Spleen , 2003, The Journal of experimental medicine.
[111] E. Montecino-Rodriguez,et al. B-1 B cell development in the fetus and adult. , 2012, Immunity.
[112] D. Schatz,et al. Somatic Hypermutation of Immunoglobulin Genes Merging Mechanisms for Genetic Diversity , 2002, Cell.
[113] R. Bram,et al. BCMA Is Essential for the Survival of Long-lived Bone Marrow Plasma Cells , 2004, The Journal of experimental medicine.
[114] David M. Beck,et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.
[115] D. Gray,et al. TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells , 2007, European journal of immunology.
[116] W. Baldwin,et al. B Cell Deficiency Confers Protection from Renal Ischemia Reperfusion Injury 1 , 2003, The Journal of Immunology.
[117] G. Vidarsson,et al. IgG-effector functions: "the good, the bad and the ugly". , 2014, Immunology letters.
[118] Z. Dai,et al. Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts. , 1999, Transplantation.
[119] M. Sarwal,et al. Characterization of intra-graft B cells during renal allograft rejection. , 2008, Kidney international.
[120] U. Klein,et al. The diverse roles of IRF4 in late germinal center B‐cell differentiation , 2012, Immunological reviews.
[121] T. Rothstein,et al. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70− , 2011, The Journal of experimental medicine.
[122] B. Rovin,et al. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR). , 2015, Nephron.
[123] G. Ewald,et al. Donor-specific antibodies to human leukocyte antigens are associated with and precede antibodies to major histocompatibility complex class I-related chain A in antibody-mediated rejection and cardiac allograft vasculopathy after human cardiac transplantation. , 2010, Human immunology.
[124] A. Gaber,et al. Bortezomib in Kidney Transplantation , 2010, Journal of transplantation.
[125] M. Scott,et al. Normal B Cell Homeostasis Requires B Cell Activation Factor Production by Radiation-resistant Cells , 2003, The Journal of experimental medicine.
[126] P. Merkel,et al. Efficacy of remission-induction regimens for ANCA-associated vasculitis. , 2013, The New England journal of medicine.
[127] Wu Xin-xing,et al. CD19+CD5+ B cells in primary IgA nephropathy. , 2008, Journal of the American Society of Nephrology : JASN.
[128] K. Calame,et al. Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow , 2005, The Journal of experimental medicine.
[129] C. Cohen,et al. Intrarenal production of B-cell survival factors in human lupus nephritis , 2011, Modern Pathology.
[130] R. Horton,et al. Visualization of splenic marginal zone B cell shuttling and follicular B cell egress , 2012, Nature.
[131] P. Lipsky,et al. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. , 2008, Arthritis and rheumatism.
[132] U. Klein,et al. Article Transcriptional Regulation of Germinal Center B and Plasma Cell Fates by Dynamical Control of Irf4 , 2022 .
[133] J. Platt,et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation , 2004, Nature Medicine.
[134] D. Gray,et al. TLR and B Cell Receptor Signals to B Cells Differentially Program Primary and Memory Th1 Responses to Salmonella enterica , 2010, The Journal of Immunology.
[135] C. Tato,et al. Innate IL-17-producing cells: the sentinels of the immune system , 2010, Nature Reviews Immunology.
[136] P. Emery,et al. B cell biomarkers of rituximab responses in systemic lupus erythematosus. , 2011, Arthritis and rheumatism.
[137] T. Honjo,et al. Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.
[138] R. Colvin,et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. , 2001, Journal of the American Society of Nephrology : JASN.
[139] J. Coles,et al. ABO-incompatible heart transplantation in infants. , 2001, The New England journal of medicine.
[140] S. Tangye. To B1 or not to B1: that really is still the question! , 2013, Blood.
[141] Kenneth G. C. Smith,et al. FcγRIIB in autoimmunity and infection: evolutionary and therapeutic implications , 2010, Nature Reviews Immunology.
[142] K. Latinis,et al. Effect of Belimumab on Vaccine Antigen Antibodies to Influenza, Pneumococcal, and Tetanus Vaccines in Patients with Systemic Lupus Erythematosus in the BLISS-76 Trial , 2012, The Journal of Rheumatology.
[143] J. Cyster,et al. S1PR2 links germinal center confinement and growth regulation , 2012, Immunological reviews.
[144] T. Tedder,et al. Regulatory B cells as inhibitors of immune responses and inflammation , 2008, Immunological reviews.
[145] R. Ahmed,et al. A Specific Role for B Cells in the Generation of CD8 T Cell Memory by Recombinant Listeria monocytogenes 1 , 2003, The Journal of Immunology.
[146] J. Kearney,et al. Marginal-zone B cells , 2002, Nature Reviews Immunology.
[147] H. Schild,et al. Donor and host B cell‐derived IL‐10 contributes to suppression of graft‐versus‐host disease , 2014, European journal of immunology.
[148] Hedda Wardemann,et al. B-cell tolerance checkpoints in health and autoimmunity. , 2008, Current opinion in immunology.
[149] Gillian Dekkers,et al. IgG Subclasses and Allotypes: From Structure to Effector Functions , 2014, Front. Immunol..
[150] O. Fjeldborg,et al. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. , 1966, Lancet.
[151] Yichun Hu,et al. Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximab. , 2013, Clinical journal of the American Society of Nephrology : CJASN.
[152] M. Sarwal,et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. , 2003, The New England journal of medicine.
[153] P. Heeringa,et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. , 2002, The Journal of clinical investigation.
[154] S. Liossis,et al. Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments , 2014, Expert Opinion on Pharmacotherapy.
[155] J. Ritz,et al. B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways. , 2012, Blood.
[156] R. Sachidanandam,et al. Antibodies reactive to non-HLA antigens in transplant glomerulopathy. , 2011, Journal of the American Society of Nephrology : JASN.
[157] G. Yaari,et al. Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone. , 2011, Immunity.
[158] I. Pastan,et al. CD21−/low Marginal Zone B Cells Highly Express Fc Receptor–like 5 Protein and Are Killed by Anti–Fc Receptor–like 5 Immunotoxins in Hepatitis C Virus–Associated Mixed Cryoglobulinemia Vasculitis , 2014, Arthritis & rheumatology.
[159] T. Rothstein,et al. A small CD11b+ human B1 cell subpopulation stimulates T cells and is expanded in lupus , 2011, The Journal of experimental medicine.
[160] R. Cron,et al. Rituximab therapy for severe refractory chronic Henoch-Schönlein purpura. , 2009, The Journal of pediatrics.
[161] A. Cappione,et al. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. , 2005, The Journal of clinical investigation.
[162] D. Gray,et al. Primary T Cell Expansion and Differentiation In Vivo Requires Antigen Presentation by B Cells1 , 2006, The Journal of Immunology.
[163] C. Kallenberg,et al. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission. , 2014, Rheumatology.
[164] M. Nussenzweig,et al. Predominant Autoantibody Production by Early Human B Cell Precursors , 2003, Science.
[165] F. Mackay,et al. Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus , 2013, Lupus.
[166] Huaxi Xu,et al. Cutting Edge: Novel Function of B Cell-Activating Factor in the Induction of IL-10–Producing Regulatory B Cells , 2010, The Journal of Immunology.
[167] S. Brouard,et al. BAFF and BAFF‐R Levels Are Associated With Risk of Long‐Term Kidney Graft Dysfunction and Development of Donor‐Specific Antibodies , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[168] C. Pusey,et al. B-cell-targeted therapy in adult glomerulonephritis , 2013, Expert opinion on biological therapy.
[169] S. Segerer,et al. B cells and tertiary lymphoid organs in renal inflammation. , 2008, Kidney international.
[170] Irene Puga,et al. Activation of B cells by non‐canonical helper signals , 2012, EMBO reports.
[171] T. Coffman,et al. B Lymphocytes Differentially Influence Acute and Chronic Allograft Rejection in Mice , 2011, The Journal of Immunology.
[172] J. Pers,et al. Maturation and function of human dendritic cells are regulated by B lymphocytes. , 2012, Blood.
[173] T. Kurosaki,et al. Memory B cells , 2015, Nature Reviews Immunology.
[174] M. Fujimoto,et al. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. , 2008, The Journal of clinical investigation.
[175] S. Tangye,et al. IL-21-Induced Isotype Switching to IgG and IgA by Human Naive B Cells Is Differentially Regulated by IL-41 , 2008, The Journal of Immunology.
[176] R. Fairchild,et al. Role of TNFα in Early Chemokine Production and Leukocyte Infiltration into Heart Allografts , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[177] R. Maul,et al. Different B Cell Populations Mediate Early and Late Memory During an Endogenous Immune Response , 2011, Science.
[178] Liping Huang,et al. Natural IgM Anti-Leukocyte Autoantibodies Attenuate Excess Inflammation Mediated by Innate and Adaptive Immune Mechanisms Involving Th-17 , 2012, The Journal of Immunology.
[179] C. Pusey,et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[180] G. Chalasani,et al. B Cells Help Alloreactive T Cells Differentiate Into Memory T Cells , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[181] J. Cyster,et al. Splenic T Zone Development Is B Cell Dependent , 2001, The Journal of experimental medicine.
[182] Kenneth G. C. Smith,et al. Local renal autoantibody production in lupus nephritis. , 2011, Journal of the American Society of Nephrology : JASN.
[183] E. Morelon,et al. Intragraft Th17 Infiltrate Promotes Lymphoid Neogenesis and Hastens Clinical Chronic Rejection , 2010, The Journal of Immunology.
[184] Masaki Kobayashi,et al. Serum Levels of BAFF and APRIL in Myeloperoxidase Anti-Neutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis: Association with Disease Activity , 2011, Nephron Clinical Practice.
[185] A. Finnegan,et al. Expression of CD80/86 on B Cells Is Essential for Autoreactive T Cell Activation and the Development of Arthritis1 , 2007, The Journal of Immunology.
[186] J. Cyster,et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5 , 2004, Nature Immunology.
[187] Philip D. Hodgkin,et al. The generation of antibody-secreting plasma cells , 2015, Nature Reviews Immunology.
[188] E. Meffre,et al. In Situ B Cell-Mediated Immune Responses and Tubulointerstitial Inflammation in Human Lupus Nephritis , 2011, The Journal of Immunology.
[189] C. Bailey-Kellogg,et al. Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. , 2013, The Journal of clinical investigation.
[190] E. S. St. Clair,et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. , 2011, Blood.
[191] K. Brorson,et al. Post-translational structural modifications of immunoglobulin G and their effect on biological activity , 2014, Analytical and Bioanalytical Chemistry.
[192] M. Rybojad,et al. Successful outcome using rituximab as the only immunomodulation in Henoch-Schonlein purpura: case report. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.